




Searching News Database: Enterin
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 29 Apr 2022
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
OncoSec Appoints Dr. Robert Arch as President and Chief Executive Officer
HSMN NewsFeed - 4 Apr 2022
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
Ardelyx Announces US Launch of IBSRELA(R), a New First-in-Class Treatment for IBS-C in Adults
HSMN NewsFeed - 2 Feb 2022
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
Medtronic announces first procedure in Europe with Hugo(TM) robotic-assisted surgery system
HSMN NewsFeed - 20 Jan 2022
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
BioTheryX Announces Appointment of Sahm Nasseri as Chief Business Officer
HSMN NewsFeed - 4 Nov 2021
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
NeuroBo Pharmaceuticals Appoints Gil Price, M.D. as President and Chief Executive Officer
HSMN NewsFeed - 26 Oct 2021
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
BD Begins Shipments Of First Smartphone Interpreted Over-The-Counter Rapid COVID-19 Test
HSMN NewsFeed - 15 Sep 2021
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
Theravance Biopharma, Inc. Announces Strategic Actions to Focus on Respiratory Disease Portfolio
HSMN NewsFeed - 13 Aug 2021
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
Memic Innovative Surgery Ltd. and MedTech Acquisition Corporation Announce Proposed Business Combination
HSMN NewsFeed - 27 Apr 2021
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
NeuroOne Appoints Medtronic Veteran, Hijaz Haris, as Vice President of Marketing
HSMN NewsFeed - 15 Apr 2021
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
HSMN NewsFeed - 22 Dec 2020
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
Update On SOURCE Phase 3 Trial For Tezepelumab In Patients With Severe, Oral Corticosteroid-Dependent Asthma
HSMN NewsFeed - 26 Oct 2020
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
Jazz Pharmaceuticals Acquires SpringWorks Therapeutics' FAAH Inhibitor Program
HSMN NewsFeed - 14 Sep 2020
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
Varian Announces Appointment of Chris Toth as President and Chief Operating Officer
HSMN NewsFeed - 2 Aug 2020
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
Varian to Combine with Siemens Healthineers in $16.4 Billion All-Cash Transaction
HSMN NewsFeed - 19 May 2020
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
Amplyx Pharmaceuticals Adds Pfizer and Adage to Series C Financing, Bringing Total to over 90 Million
HSMN NewsFeed - 26 Mar 2020
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
Immunexpress Receives CE Mark and Signs European Commercialization Partnership for SeptiCyte(R) RAPID
HSMN NewsFeed - 18 Oct 2019
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
Nplate(R) (romiplostim) Now Approved For Earlier Use In Adults With Immune Thrombocytopenia
HSMN NewsFeed - 24 Sep 2019
Artios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States
Artios Pharma Appoints Tania Dimitrova as Chief Business Officer and Expands Presence in the United States
HSMN NewsFeed - 15 Jul 2019
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
ESSA Expands Leadership Team by appointing Alessandra Cesano as Chief Medical Officer
HSMN NewsFeed - 28 Jun 2019
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
Amgen and UCB Provide Regulatory Update on Status of EVENITY(TM) (romosozumab) in the EU
HSMN NewsFeed - 25 Jun 2019
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer
HSMN NewsFeed - 29 May 2019
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
ReWalk Robotics Receives CE Mark for ReStore(TM) Exo-Suit Stroke Rehabilitation Device
HSMN NewsFeed - 28 Feb 2019
Bardy Diagnostics(TM) Announces Expansion into Canadian Market with Distributor JNC Medical
Bardy Diagnostics(TM) Announces Expansion into Canadian Market with Distributor JNC Medical
HSMN NewsFeed - 13 Nov 2018
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
Sobi(TM) to Acquire Synagis(R) US Rights From AstraZeneca - Creates a Platform for Global Growth
HSMN NewsFeed - 5 Nov 2018
Biocept Announces New Executive Hires to its Sales and Marketing Organization
Biocept Announces New Executive Hires to its Sales and Marketing Organization
HSMN NewsFeed - 29 Oct 2018
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
OncoSec Appoints Kellie Malloy Foerter as Chief Clinical Development Officer
HSMN NewsFeed - 2 Oct 2018
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
ViewRay Appoints Industry Veteran James Alecxih as Chief Commercial Officer
HSMN NewsFeed - 17 Sep 2018
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
Halozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin(R)) In Canada
HSMN NewsFeed - 13 Sep 2018
XACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous Procedures
XACT Robotics Receives CE Mark for Its Robotics Navigation System for Percutaneous Procedures
HSMN NewsFeed - 10 Sep 2018
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
Biocept Names Edwin C. Hendrick as Senior Vice President, Chief Commercial Officer
HSMN NewsFeed - 5 Sep 2018
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
Compugen Announces Appointment of Dr. Jean-Pierre Bizzari to its Board of Directors
HSMN NewsFeed - 28 Aug 2018
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
Study Shows Improved Quality of Life and Reduced Symptoms In Patients Treated with Medtronic Cryoballoon
HSMN NewsFeed - 30 Jul 2018
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
Enzyvant Expands Leadership Team with Appointments of Andrew Dawson and Alex Tracy
HSMN NewsFeed - 26 Jul 2018
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
Phase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE(R) Technology
HSMN NewsFeed - 13 Jul 2018
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
Amgen And UCB Resubmit Biologics License Application (BLA) For EVENITY(TM) (romosozumab) To The US FDA
HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
HSMN NewsFeed - 28 Jun 2018
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
Corporate Biotech Executive Mark Germain Joins BiondVax's Board of Directors
HSMN NewsFeed - 27 Jun 2018
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
Beckman Coulter Diagnostics Receives U.S. FDA 510(k) Clearance for High- sensitivity Access hsTnI Assay
HSMN NewsFeed - 13 Jun 2018
BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
BridgeBio Pharma Launches CoA Therapeutics to Target Coenzyme-A for Rare Genetic Disorders
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 22 May 2018
AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
AbelsonTaylor Hires Amanda Hartzmark as Director of Business Development and Analysis
HSMN NewsFeed - 18 May 2018
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
FDA Approves Aimovig(TM) (erenumab-aooe), A Novel Treatment Developed Specifically For Migraine Prevention
HSMN NewsFeed - 8 May 2018
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
NRG(R) Transseptal Needle Associated with a 40% Lower Risk of Silent Cerebral Embolism
HSMN NewsFeed - 6 Mar 2018
Corin Group Launches Trinity(TM) Dual Mobility System for Hip Replacement at AAOS 2018 Annual Meeting
Corin Group Launches Trinity(TM) Dual Mobility System for Hip Replacement at AAOS 2018 Annual Meeting
HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
HSMN NewsFeed - 9 Jan 2018
ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
ClearLine MD(TM) Secures $5.5MM Funding for Commercialization of ClearLine IV(TM)
HSMN NewsFeed - 6 Nov 2017
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
HSMN NewsFeed - 26 Oct 2017
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
Teijin Nakashima Medical to Acquire Spinal-related Business of Century Medical
HSMN NewsFeed - 28 Sep 2017
Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA(TM)
Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA(TM)
HSMN NewsFeed - 29 Aug 2017
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
Sorrento Therapeutics, Inc. Submits NDA For ZTlido(TM) Next-Generation Lidocaine Patch
HSMN NewsFeed - 14 Aug 2017
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR
HSMN NewsFeed - 17 Jul 2017
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
Amgen And UCB Provide Update On Regulatory Status Of EVENITY(TM) (romosozumab) In The US
HSMN NewsFeed - 20 Apr 2017
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
Japan's Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher-Smith Laboratories
HSMN NewsFeed - 11 Apr 2017
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
Valeo Pharma and Zambon form partnership for Parkinson's Disease Treatment Xadago(R) (safinamide) in Canada
HSMN NewsFeed - 13 Mar 2017
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
Lycera Announces the Appointment of Pablo J. Cagnoni, M.D., to the Board of Directors
HSMN NewsFeed - 22 Feb 2017
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
Symbiomix Therapeutics Appoints David L. Stern as Chief Executive Officer
HSMN NewsFeed - 22 Feb 2017
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
Repatha(R) (Evolocumab) Receives European Commission Approval For New 420 mg Single-Dose Delivery Option
HSMN NewsFeed - 1 Feb 2017
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
Syneron Medical Strengthens Senior Management Team with Appointment of Chief Human Resources Officer
HSMN NewsFeed - 9 Jan 2017
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
Amgen and Immatics Enter Strategic Collaboration to Develop Novel Bispecific Cancer Immunotherapies
HSMN NewsFeed - 28 Oct 2016
AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke
AliveCor Unveils Medical Grade Mobile App to Manage Top Risk Factors for Stroke
HSMN NewsFeed - 12 Oct 2016
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
Inovio Expands Executive Team to Advance its DNA Immunotherapy Product Portfolio
HSMN NewsFeed - 29 Sep 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
HSMN NewsFeed - 6 Sep 2016
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
OncoSec Appoints Sharron Gargosky, PhD, to Chief Clinical and Regulatory Officer
HSMN NewsFeed - 15 Aug 2016
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
Arena Pharmaceuticals Announces Appointment of Vincent Aurentz as Chief Business Officer
HSMN NewsFeed - 28 Jul 2016
Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally Invasive Spinal Fixation System
Orthofix Announces Japanese Approval and Market Launch of PHOENIX Minimally Invasive Spinal Fixation System
HSMN NewsFeed - 25 Jul 2016
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
Neuravi Selects Robert Colloton to Lead U.S. Commercialization of Innovative Stent Retriever
HSMN NewsFeed - 20 Jul 2016
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
Cellectar Biosciences Appoints Jarrod Longcor Senior Vice President of Corporate Development and Operations
HSMN NewsFeed - 12 Jul 2016
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access & Corporate Accounts
HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
HSMN NewsFeed - 2 Feb 2016
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit
HSMN NewsFeed - 14 Jan 2016
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events
HSMN NewsFeed - 21 Dec 2015
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
Halozyme Enters Into Global Collaboration And Licensing Agreement With Lilly
HSMN NewsFeed - 16 Dec 2015
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
BIND Therapeutics Appoints Jonathan Yingling, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 13 Oct 2015
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
GTx Receives FDA Clearance to Initiate Clinical Trial in Stress Urinary Incontinence
HSMN NewsFeed - 24 Sep 2015
KARL STORZ’s New FLEX-GUARD System is Designed to Reduce Repair Costs of Flexible Ureterscopes
KARL STORZ’s New FLEX-GUARD System is Designed to Reduce Repair Costs of Flexible Ureterscopes
HSMN NewsFeed - 25 Aug 2015
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
Regulus Appoints Michael Huang, M.D. as Vice President, Clinical Development
HSMN NewsFeed - 5 Aug 2015
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
InteloMed, Inc. Appoints Jill Schiaparelli President and Chief Executive Officer
HSMN NewsFeed - 16 Jun 2015
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
Cellectar Appoints Industry Veteran Jim Caruso President and Chief Executive Officer
HSMN NewsFeed - 31 Mar 2015
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
Tyrogenex, Xcovery Appoint Michael Webb as President and Chief Executive Officer
HSMN NewsFeed - 17 Feb 2015
Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven
Regen BioPharma, Inc. Expands Management Team With the Addition of New CFO Todd Caven
HSMN NewsFeed - 28 Jan 2015
University of Oklahoma Proton Therapy System Enters Clinical Commissioning
University of Oklahoma Proton Therapy System Enters Clinical Commissioning
HSMN NewsFeed - 30 Oct 2014
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System
Hansen Medical Announces Global Launch of the Sensei X2(R) Robotic System
HSMN NewsFeed - 9 Oct 2014
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion
HSMN NewsFeed - 3 Sep 2014
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
Eisai Sells U.S. Rights to Zonegran(R) (zonisamide) Capsules to Concordia Pharmaceuticals Inc.
HSMN NewsFeed - 12 Aug 2014
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer
HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
HSMN NewsFeed - 22 Jul 2014
Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter
Teleflex Receives FDA Clearance for ARROW-Clark(TM) VectorFlow(TM) Chronic Hemodialysis Catheter
HSMN NewsFeed - 28 May 2014
Hansen Medical Announces First Clinical Cases in United States With New Magellan(TM) 6Fr Robotic Catheter
Hansen Medical Announces First Clinical Cases in United States With New Magellan(TM) 6Fr Robotic Catheter
HSMN NewsFeed - 9 Apr 2014
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
Chimerix Announces Appointment of M. Michelle Berrey, M.D., M.P.H. as Chief Executive Officer
HSMN NewsFeed - 25 Feb 2014
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
InterMune Reports Phase 3 ASCEND Trial Results of Pirfenidone in Idiopathic Pulmonary Fibrosis (IPF)
HSMN NewsFeed - 10 Feb 2014
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
Mast Therapeutics Signs Definitive Agreement To Acquire Aires Pharmaceuticals, Inc.
HSMN NewsFeed - 7 Jan 2014
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
AMAG Pharmaceuticals Appoints Elizabeth Bolgiano as Senior Vice President of Human Resources
HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
HSMN NewsFeed - 3 Dec 2013
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
BioDelivery Sciences Announces Hiring of David Acheson as Vice President of Sales and Managed Markets
HSMN NewsFeed - 2 Dec 2013
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
InspireMD Appoints Rick Olson as Vice President of Global Sales Operations
HSMN NewsFeed - 30 Sep 2013
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
Amgen Presents New Data From Phase 3 Study Of Talimogene Laherparepvec In Patients With Metastatic Melanoma
HSMN NewsFeed - 31 Jul 2013
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
Hansen Medical Enters Into Agreement With Investors to Receive up to $93 Million in Equity Financing
HSMN NewsFeed - 17 Jul 2013
Hansen Medical and Philips Reinforce Collaboration in Robotic Systems for Endovascular Interventions
Hansen Medical and Philips Reinforce Collaboration in Robotic Systems for Endovascular Interventions
HSMN NewsFeed - 24 Jun 2013
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
AMAG Pharmaceuticals Appoints Steven Caffe, M.D. as Chief Development and Regulatory Officer
HSMN NewsFeed - 13 Jun 2013
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
FDA Approves Amgen's XGEVA(R) (denosumab) For The Treatment Of Giant Cell Tumor Of Bone
HSMN NewsFeed - 12 Jun 2013
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
Amgen Announces Top-Line Results Of Phase 3 Trebananib (AMG 386) TRINOVA-1 Trial In Recurrent Ovarian Cancer
HSMN NewsFeed - 5 Jun 2013
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
HSMN NewsFeed - 21 May 2013
Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
Accumed Radial Systems, LLC Names Michael Pisano, PhD, as President and Chief Executive Officer
HSMN NewsFeed - 18 Mar 2013
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
Spectrum Pharmaceuticals Appoints Lee F. Allen, M.D., Ph.D., Industry Veteran, as Chief Medical Officer
HSMN NewsFeed - 14 Feb 2013
Hansen Medical Appoints Will Sutton as Chief Operating Officer Responsible for Engineering and Manufacturing
Hansen Medical Appoints Will Sutton as Chief Operating Officer Responsible for Engineering and Manufacturing
HSMN NewsFeed - 29 Jan 2013
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
Spectranetics Announces Expansion Into Japan Peripheral Intervention Market
HSMN NewsFeed - 16 Jan 2013
Hansen Medical Names Robert Cathcart Senior Vice President of Global Sales
Hansen Medical Names Robert Cathcart Senior Vice President of Global Sales
HSMN NewsFeed - 28 Dec 2012
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
Perrigo Company Acquires Remaining Stake in Cobrek Pharmaceuticals, Inc. for Approximately $45 Million
HSMN NewsFeed - 21 Dec 2012
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
Christopher S. Destro Joins Atossa Genetics as Vice President of Sales and Marketing
HSMN NewsFeed - 18 Dec 2012
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
Celator(R) Pharmaceuticals Announces Appointment of Fred Powell as Chief Financial Officer
HSMN NewsFeed - 4 Dec 2012
Lenstec Expands Precision Line of IOLs With New Softec HD Oval Intraocular Lens
Lenstec Expands Precision Line of IOLs With New Softec HD Oval Intraocular Lens
HSMN NewsFeed - 19 Nov 2012
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
Wright Medical Group, Inc. and BioMimetic Therapeutics, Inc. Enter into Agreement to Combine Businesses
HSMN NewsFeed - 15 Nov 2012
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
Targacept Appoints Stephen A. Hill, M.D., President and Chief Executive Officer
HSMN NewsFeed - 15 Aug 2012
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
Astellas Pharma Europe Ltd. Appoints Dr Susan Wood as Senior Director, Market Access
HSMN NewsFeed - 1 May 2012
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
Dr. Frank Basile Joins Miraca Life Sciences as President and Chief Executive Officer
HSMN NewsFeed - 27 Mar 2012
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
Third Rock Ventures Appoints Mark A. Goldsmith, M.D., Ph.D., as Venture Partner
HSMN NewsFeed - 22 Feb 2012
Teleflex Signs Regional Anesthesia Agreement with German Asklepios Hospital Group for ambIT(R) PCA Pump
Teleflex Signs Regional Anesthesia Agreement with German Asklepios Hospital Group for ambIT(R) PCA Pump
HSMN NewsFeed - 20 Feb 2012
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
Theragenics Acquires Core Oncology’s Prostate Brachytherapy Customer Base
HSMN NewsFeed - 6 Dec 2011
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
Amgen and FDA Agree to Modify Nplate(R) (Romiplostim) Risk Evaluation and Mitigation Strategy
HSMN NewsFeed - 14 Nov 2011
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
Genzyme Announces Successful Phase III Results for Alemtuzumab (LEMTRADA(TM*)) in Multiple Sclerosis
HSMN NewsFeed - 18 Oct 2011
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
Tranzyme Pharma Names Former Gilead Executive Franck Rousseau, M.D. Chief Medical Officer
HSMN NewsFeed - 17 Aug 2011
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
Labopharm Inc. Enters Into an Agreement to Be Acquired by Paladin Labs Inc.
HSMN NewsFeed - 15 Jul 2011
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
XGEVA(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed - 2 Jun 2011
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
GSK and Theravance Announce Results of Two Pivotal Phase III Studies for Relovair(TM) in COPD
HSMN NewsFeed - 25 May 2011
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients
HSMN NewsFeed - 20 May 2011
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
Amgen Receives CHMP Positive Opinion for XGEVA (Denosumab) in the European Union
HSMN NewsFeed - 29 Mar 2011
Elekta Software Making Strong Inroads in Clinics Providing Proton Therapy for Patients with Cancer
Elekta Software Making Strong Inroads in Clinics Providing Proton Therapy for Patients with Cancer
HSMN NewsFeed - 3 Mar 2011
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
BoneGrafix Moves Forward with Development of Next Generation Bone Repair Products
HSMN NewsFeed - 24 Jan 2011
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
Clinical Data, Inc. Announces FDA Approval of Viibryd(TM) (vilazodone HCl) for Major Depressive Disorder
HSMN NewsFeed - 20 Jan 2011
St. Jude Medical Reaches Settlement with United States Department of Justice
St. Jude Medical Reaches Settlement with United States Department of Justice
HSMN NewsFeed - 20 Jan 2011
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
EDAP Continues Its Growth Strategy; Enters New Major Market for Lithotripsy
HSMN NewsFeed - 5 Jan 2011
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
Biogen Idec Appoints Doug Williams to Head R&D, Steven Holtzman to Head Corporate Development
HSMN NewsFeed - 17 Dec 2010
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
InterMune Announces Senior Leadership Appointments to Prepare for Launch of Esbriet (Pirfenidone) in Europe
HSMN NewsFeed - 17 Dec 2010
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
Pier Pharmaceuticals Names Peter Letendre as Chief Executive Officer, President and Director
HSMN NewsFeed - 17 Dec 2010
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
InterMune Announces Positive Opinion for Approval of Esbriet (Pirfenidone) in European Union
HSMN NewsFeed - 15 Dec 2010
Orthofix International Announces Reorganization And Settlement with NuVasive and Osiris Therapeutics
Orthofix International Announces Reorganization And Settlement with NuVasive and Osiris Therapeutics
HSMN NewsFeed - 13 Dec 2010
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
XGEVA (Denosumab) Significantly Improved Bone Metastasis-Free Survival in Men With Prostate Cancer
HSMN NewsFeed - 9 Dec 2010
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
Teva Announces Successful Results of Phase III Study with Oral Laquinimod for Multiple Sclerosis
HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
HSMN NewsFeed - 14 Oct 2010
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
Catabasis Pharmaceuticals Appoints Michael Curtis, Ph.D., as Vice President, Product Development
HSMN NewsFeed - 31 Aug 2010
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
Dr. Les Paul Joins Caris Life Sciences as Senior Vice President, Medical Affairs
HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
HSMN NewsFeed - 28 May 2010
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
Prolia(R) (Denosumab) Granted Marketing Authorization in the European Union
HSMN NewsFeed - 17 May 2010
Covidien Enters Hemorrhoidopexy Market with New Hemorrhoid Stapling Technology
Covidien Enters Hemorrhoidopexy Market with New Hemorrhoid Stapling Technology
HSMN NewsFeed - 10 May 2010
AngioDynamics Launches Improved Centros(R) Self-Centering Hemodialysis Catheter
AngioDynamics Launches Improved Centros(R) Self-Centering Hemodialysis Catheter
HSMN NewsFeed - 26 Mar 2010
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
Cortex Sells Selected AMPAKINE Compounds and Rights to Respiratory Depression Indication to Biovail
HSMN NewsFeed - 18 Mar 2010
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
Somaxon Announces FDA Approval of Silenor(R) (doxepin) for the Treatment of Insomnia
HSMN NewsFeed - 11 Mar 2010
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
Illumina and Glenn Close Announce the First Full Coverage DNA Sequencing of a Named Female
HSMN NewsFeed - 8 Mar 2010
X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology
X-spine Announces Exclusive License with Gamma Spine for Minimally-Invasive Spinal Technology
HSMN NewsFeed - 1 Mar 2010
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
HSMN NewsFeed - 19 Feb 2010
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
FDA Classifies Prolia(TM) (Denosumab) Complete Response Submission and Targets Action Date
HSMN NewsFeed - 2 Feb 2010
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
Sensors for Medicine and Science, Inc. Names Dr. Paul Strumph as Chief Medical Officer
HSMN NewsFeed - 22 Dec 2009
Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board
Professor Riccardo Lencioni Joins Delcath Systems' Scientific Advisory Board
HSMN NewsFeed - 16 Dec 2009
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
Nanotherapeutics Acquires Two Late Stage Clinical Programs for Alzheimer's Treatment and CDA Disease
HSMN NewsFeed - 2 Dec 2009
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
Amarin Corporation Appoints Industry Veteran Joseph Zakrzewski as Executive Chairman
HSMN NewsFeed - 30 Nov 2009
Medipattern and Sentinelle Medical Inc. Announce Breast MRI Development Partnership
Medipattern and Sentinelle Medical Inc. Announce Breast MRI Development Partnership
HSMN NewsFeed - 27 Nov 2009
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
Theravance Receives Complete Response Letter on the Telavancin NDA for the Treatment of Nosocomial Pneumonia
HSMN NewsFeed - 5 Nov 2009
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 23 Oct 2009
Delcath Systems Completes Executive Management Team with Strategic New Hires
Delcath Systems Completes Executive Management Team with Strategic New Hires
HSMN NewsFeed - 19 Oct 2009
Covidien Announces Global Launch of Mallinckrodt TaperGuard Line of Endotracheal Tubes
Covidien Announces Global Launch of Mallinckrodt TaperGuard Line of Endotracheal Tubes
HSMN NewsFeed - 6 Oct 2009
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
SurModics Enters Ophthalmic License and Development Agreement with Roche and Genentech
HSMN NewsFeed - 23 Sep 2009
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
BurnsAdler Partners With Three Rivers Pharmaceuticals to Commercialize Infergen(R) in Brazil and Chile
HSMN NewsFeed - 17 Aug 2009
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
Additional items found! 495

Members Archive contains
495 additional stories matching:
Enterin
(Password required)
Enterin
(Password required)